In continuation to letter dated November 22, 2022, regarding the Postal Ballot Notice seeking approval of Members of the Company, through remote e-voting, by way of special resolution, for appointment of Prasad Raghava Menon (DIN: 00005078) as an Independent Director of the Company with effect from October 31, 2022, for a period of 5 years (The aforesaid resolution has been passed by Members through Postal Ballot by remote e-voting process with requisite majority) and in accordance with Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Neuland Laboratories has informed that it the summarized voting result of the remote e-voting, in the prescribed format, along with a copy of the Scrutinizer’s Report, is enclosed as ‘Annexure A’.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1652.00 |
| Dr. Reddys Lab | 1235.20 |
| Cipla | 1211.30 |
| Zydus Lifesciences | 923.10 |
| Lupin | 2312.35 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: